The future of biomarkers for vascular contributions to cognitive impairment and dementia (VCID): proceedings of the 2025 annual workshop of the Albert research institute for white matter and cognition
Authors:
- Matthew J LennonMLMatthew J Lennon
- Nikolaos KarvelasNKNikolaos Karvelas
- Aravind GaneshAGAravind Ganesh
- Shawn WhiteheadSWShawn Whitehead
- Farzaneh A SorondFSFarzaneh A Sorond
- Violeta Durán LaforetVLVioleta Durán Laforet
- Elizabeth HeadEHElizabeth Head
- Konstantinos ArfanakisKAKonstantinos Arfanakis
- Vijaya B KolachalamaVKVijaya B Kolachalama
- Xiao LiuXLXiao Liu
- Hanzhang LuHLHanzhang Lu
- Joel RamirezJRJoel Ramirez
Open Access
- 21 June 2025
- journal article
- research article
- Published by Springer Nature in GeroScience
- Vol. 47 (5) , 6177-6190
Abstract
Advances in biomarkers and pathophysiology of vascular contributions to cognitive impairment and dementia (VCID) are expected to bring greater mechanistic insights, more targeted treatments, and potentially disease-modifying therapies. The 2025 Annual Workshop of the Albert Research Institute for White Matter and Cognition, sponsored by the Leo and Anne Albert Charitable Trust since 2015, focused on novel biomarkers for VCID. The meeting highlighted the complexity of dementia, emphasizing that the majority of cases involve multiple brain pathologies, with vascular pathology typically present. Potential novel approaches to diagnosis of disease processes and progression that may result in VCID included measures of microglial senescence and retinal changes, as well as artificial intelligence (AI) integration of multimodal datasets. Proteomic studies identified plasma proteins associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL; a rare genetic disorder affecting brain vessels) and age-related vascular pathology that suggested potential therapeutic targets. Blood-based microglial and brain-derived extracellular vesicles are promising tools for early detection of brain inflammation and other changes that have been associated with cognitive decline. Imaging measures of blood perfusion, oxygen extraction, and cerebrospinal fluid (CSF) flow were discussed as potential VCID biomarkers, in part because of correlations with classic pathological Alzheimer’s disease (AD) biomarkers. MRI-visible perivascular spaces, which may be a novel imaging biomarker of sleep-driven glymphatic waste clearance dysfunction, are associated with vascular risk factors, lower cognitive function, and various brain pathologies including Alzheimer’s, Parkinson’s and cerebral amyloid angiopathy (CAA). People with Down syndrome are at high risk for dementia. Individuals with Down syndrome who develop dementia almost universally experience mixed brain pathologies, with AD pathology and cerebrovascular pathology being the most common. This follows the pattern in the general population where mixed pathologies are also predominant in the brains of people clinically diagnosed with dementia, including AD dementia. Intimate partner violence-related brain injury, hypertension’s impact on dementia risk, and the promise of remote ischemic conditioning for treating VCID were additional themes.Keywords
Funding Information
- Albert White Matter Research Institute
- University of New South Wales
This publication has 42 references indexed in Scilit:
- Plasma proteomic characterization of motoric cognitive risk and mild cognitive impairmentAlzheimer's & Dementia, 2025
- Perivascular spaces, plasma GFAP, and speeded executive function in neurodegenerative diseasesAlzheimer's & Dementia, 2024
- Use of Antihypertensives, Blood Pressure, and Estimated Risk of Dementia in Late LifeJAMA Network Open, 2023
- Longitudinal changes in brain oxygen extraction fraction (OEF) in older adults: Relationship to markers of vascular and Alzheimer's pathologyAlzheimer's & Dementia, 2022
- Small and Large Magnetic Resonance Imaging–Visible Perivascular Spaces in the Basal Ganglia of Parkinson's Disease PatientsMovement Disorders, 2022
- Replicative senescence dictates the emergence of disease-associated microglia and contributes to Aβ pathologyCell Reports, 2021
- Brain Oxygen Extraction Is Differentially Altered by Alzheimer's and Vascular DiseasesJournal of Magnetic Resonance Imaging, 2020
- Age-related changes in cerebrovascular reactivity and their relationship to cognition: A four-year longitudinal studyNeuroImage, 2018
- Imaging the Perivascular Space as a Potential Biomarker of Neurovascular and Neurodegenerative DiseasesCellular and Molecular Neurobiology, 2016
- The Science of Vascular Contributions to Cognitive Impairment and Dementia (VCID): A Framework for Advancing Research Priorities in the Cerebrovascular Biology of Cognitive DeclineCellular and Molecular Neurobiology, 2016